ReleaseWire Connect

The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Move Inc. (NASDAQ:MOVE), was launched concerning whether the takeover of Move Inc.. by News Corp for $21 per share is unfair to NASDAQ:MOVE stockholders.

The Shareholders Foundation announces that an investor, who purchased shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by AcelRx Pharmaceuticals Inc in connection with certain allegedly false and misleading statements made between December 2, 2013 and September 25, 2014.

The Shareholders Foundation announces that an investigation on behalf of investors of NewLink Genetics Corp (NASDAQ:NLNK) shares was launched over potential securities laws violations by NewLink Genetics and certain of its directors and officers in connection certain financial statements.

The Shareholders Foundation announces that an investor, who currently holds shares of Dresser-Rand Group Inc. (NYSE:DRC), filed a lawsuit in effort to halt the proposed takeover of Dresser-Rand Group Inc. by Siemens.

The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Viasystems Group, Inc. (NASDAQ:VIAS), was launched concerning whether the takeover of Viasystems Group, Inc. by TTM Technologies, Inc is unfair to NASDAQ:VIAS stockholders.

The Shareholders Foundation announces that a deadline is coming up on November 4, 2014 in the lawsuit filed for investors of Enzymotec Ltd (NASDAQ:ENZY) over alleged violations of Federal Securities Laws by Enzymotec Ltd

The Shareholders Foundation announces that an investor, who currently holds shares of Concur Technologies, Inc. (NASDAQ:CNQR), filed a lawsuit in effort to halt the proposed takeover of Concur Technologies, Inc. by SAP SE for $129 per share.

The Shareholders Foundation announces that an investor, who purchased shares of Iradimed Corp (NASDAQ:IRMD), filed a lawsuit in the U.S. District Court for the Southern District of Florida over alleged violations of Federal Securities Laws by Iradimed Corp in connection with certain allegedly false and misleading statements made between July 15, 2014 and September 2, 2014.

The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) was initiated concerning potential breaches of fiduciary duties by certain directors and officers of Galectin Therapeutics.

The Shareholders Foundation announces that an investor, who currently holds shares of XRS Corp (NASDAQ:XRSC), filed a lawsuit in effort to halt the proposed takeover of XRS by Omnitracs, LLC for $5.60 per share.